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We thank Zdravkovic et al. [1] for their comments on our
article recently published in the World Journal of Surgery
on the impact of postoperative complications on survival
after pancreaticoduodenectomy for ductal adenocarcinoma.
The key finding was that postoperative complications,
especially if severe, had a negative impact on long-term
survival. In particular, patients at increased risk for early
tumor recurrence, e.g. after incomplete R1 resection, are
concerned by the occurrence of severe complications. A
meticulous prospective assessment of complications using
a standardized classification system, e.g. the Dindo–Cla-
vien classification, usually reveals a high complication rate,
since minor complications are otherwise under-reported.
Hence, our morbidity rates represent the ‘real world’ of
pancreatic surgery. However, despite that the overall
complication rate was 57 %, severe complications (higher
than grade IIIb) occurred in only 16 %. The perpetual
debate on prevention of delayed gastric emptying (DGE),
pancreatic fistula, and postoperative hemorrhage was not
taken as an outcome in our study. Contrary to the comment
made, there is good evidence that pylorus-preserving
pancreaticoduodenectomy (PPPD) is not related to higher
DGE rates [2, 3]. The type of pancreaticojejunal anasto-
mosis to best prevent pancreatic fistula is the subject of a
large series of publications without any clear result favor-
ing a particular technique. Further, the question of pan-
creaticogastrostomy versus pancreaticojejunostomy is not
yet elucidated, as a recent meta-analysis shows no differ-
ence [4], whereas postoperative fistula was lower after
pancreaticogastrostomy in two recent randomized con-
trolled studies [5, 6].
The aim of the discussion about the impact of an R1
resection on long-term survival was to outline the multi-
plicity of the factors that could be taken into account to
improve the results. Factors related to the tumor, such as
tumor size, lymphovascular and perineural invasion, lym-
phatic node invasion, and differentiation might be balanced
with the surgeon’s impact on the disease, i.e. resection
margins and postoperative complications. Treatment of
pancreatic ductal adenocarcinoma needs multidisciplinary
care with knowledge of every parameter that could
improve survival.
R1 resection in the entire group of patients was corre-
lated with worse outcomes (1.2 vs. 1.6 years, p = 0.037).
In patients without severe postoperative complications,
survival after R1 resection was 2.0 years compared with
1.4 years after R0 resection, but this was not significant
(p = 0.27). Patients with severe postoperative complica-
tions and R1 resection had poorer outcomes (p = 0.0005).
We can agree that results are based on a small number of
patients, but even with small figures, statistical analysis
showed strong significance. Moreover, to date, to the best
of our knowledge, very few studies have specifically
addressed the problem of postoperative complications and
its impact on survival.
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